Moreover, qRT-PCR confirmed that the dual EZH2/G9a inhibition strongly suppressed expression of the four IRF4–MYC axis genes in MM cells, and that treatment with either inhibitor individually also moderately suppressed their expression (Fig. 4E). Here, IRF4 is linked to Miyoshi myopathy.